“Co-Therapy of Silymarin and Vitamin E Attenuates Doxorubicin-Induced Hepatotoxicity in Rats by Mitigating Oxidative Damage and Preserving Hepatic Architecture”. 2026. Tikrit Journal of Pharmaceutical Sciences 20 (1): 20-32. https://doi.org/10.25130/tjphs.2026.20.1.3.20.32.